Drugs Made In America Acquisition Corp. (DMAA)

DMAA Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024
Period Ending	Dec 31, 2024
Cash & Equivalents	0
Cash & Short-Term Investments	0
Prepaid Expenses	0
Total Current Assets	0
Long-Term Deferred Charges	0.55
Total Assets	0.55
Accrued Expenses	0.08
Short-Term Debt	0.66
Other Current Liabilities	0.06
Total Current Liabilities	0.8
Total Liabilities	0.8
Common Stock	0
Additional Paid-In Capital	0.03
Retained Earnings	-0.28
Shareholders' Equity	-0.24
Total Liabilities & Equity	0.55
Total Debt	0.66
Net Cash (Debt)	-0.66
Net Cash Per Share	-0.08
Filing Date Shares Outstanding	33.52
Total Common Shares Outstanding	8.57
Working Capital	-0.79
Book Value Per Share	-0.03
Tangible Book Value	-0.24
Tangible Book Value Per Share	-0.03

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q